Published in BMC Complement Altern Med on July 14, 2015
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins (2003) 32.38
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc (2010) 22.66
I-TASSER server for protein 3D structure prediction. BMC Bioinformatics (2008) 18.28
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (2013) 11.01
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science (2010) 6.29
Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol (2001) 4.92
PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta (2010) 3.62
A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet (2010) 3.25
Mitochondrial dysfunction in atherosclerosis. Circ Res (2007) 3.09
TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One (2011) 3.09
COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res (2012) 2.75
SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem (2011) 2.74
CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures. PLoS Comput Biol (2012) 2.64
HLA class II polymorphisms associated with the physiologic characteristics defined by Traditional Chinese Medicine: linking modern genetics with an ancient medicine. J Altern Complement Med (2007) 2.61
The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics (1996) 2.48
Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem (2001) 2.08
DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet (1998) 1.94
Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Comput Biol (2011) 1.61
Endothelial function and coronary artery disease. Curr Opin Lipidol (2001) 1.52
Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet (2005) 1.51
Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Comput Biol (2011) 1.33
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem (2006) 1.32
Drug design for neuropathic pain regulation from traditional Chinese medicine. Sci Rep (2013) 1.30
How to design a drug for the disordered proteins? Drug Discov Today (2013) 1.25
High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan. Mol Biosyst (2011) 1.22
One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J Biol Chem (2010) 1.22
Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chem Biol Drug Des (2011) 1.21
Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid Redox Signal (2010) 1.21
A novel integrated framework and improved methodology of computer-aided drug design. Curr Top Med Chem (2013) 1.20
Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Mol Biosyst (2011) 1.13
Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene (1998) 1.12
May disordered protein cause serious drug side effect? Drug Discov Today (2013) 1.11
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. J Biomol Struct Dyn (2012) 1.10
Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. J Ethnopharmacol (2011) 1.10
Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. PLoS One (2012) 1.08
In silico pharmacology suggests ginger extracts may reduce stroke risks. Mol Biosyst (2011) 1.06
Tissue morphogenesis and vascular stability require the Frem2 protein, product of the mouse myelencephalic blebs gene. Proc Natl Acad Sci U S A (2005) 1.03
Identifying HER2 inhibitors from natural products database. PLoS One (2011) 1.01
The role of Fras1/Frem proteins in the structure and function of basement membrane. Int J Biochem Cell Biol (2010) 1.01
Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1997) 1.00
Genome-wide association analysis of Sasang constitution in the Korean population. J Altern Complement Med (2012) 0.99
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. Mol Genet Metab (2006) 0.97
Mechanosensitive channels: in touch with Piezo. Curr Biol (2010) 0.97
Role of PCDH10 and its hypermethylation in human gastric cancer. Biochim Biophys Acta (2011) 0.96
The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal (2011) 0.95
Polymorphisms in PPARD, PPARG and APM1 associated with four types of traditional Chinese medicine constitutions. J Genet Genomics (2010) 0.93
Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res (2009) 0.92
Delta Protocadherin 10 is Regulated by Activity in the Mouse Main Olfactory System. Front Neural Circuits (2011) 0.88
Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response. Biochem J (2011) 0.88
Molecular basis for cold-intolerant yang-deficient constitution of traditional Chinese medicine. Am J Chin Med (2008) 0.87
In silico investigation of potential SRC kinase ligands from traditional Chinese medicine. PLoS One (2012) 0.86
Effects of adlay seed oil on blood lipids and antioxidant capacity in hyperlipidemic rats. J Sci Food Agric (2011) 0.85
In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine. PLoS One (2012) 0.85
The Relationship between Stasis-Stagnation Constitution and Peripheral Arterial Disease in Patients with Type 2 Diabetes. Evid Based Complement Alternat Med (2014) 0.84
[Investigation of gene expression profiles in patients with blood stasis syndrome]. Zhong Xi Yi Jie He Xue Bao (2008) 0.83
Study of the relationship between carotid intima-media thickness and traditional Chinese medicine syndrome of dyslipidemia. Chin J Integr Med (2009) 0.81
[Expression of platelet CD62p gene and leucocyte HSP70 gene in patients with blood stasis syndrome MA]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2005) 0.76